chr3-50342543-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015896.4(ZMYND10):​c.727C>T​(p.Arg243Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000898 in 1,613,592 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R243H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0032 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00066 ( 1 hom. )

Consequence

ZMYND10
NM_015896.4 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.345

Publications

3 publications found
Variant links:
Genes affected
ZMYND10 (HGNC:19412): (zinc finger MYND-type containing 10) This gene encodes a protein containing a MYND-type zinc finger domain that likely functions in assembly of the dynein motor. Mutations in this gene can cause primary ciliary dyskinesia. This gene is also considered a tumor suppressor gene and is often mutated, deleted, or hypermethylated and silenced in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
ZMYND10-AS1 (HGNC:40890): (ZMYND10 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011281699).
BP6
Variant 3-50342543-G-A is Benign according to our data. Variant chr3-50342543-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241071.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00316 (481/152296) while in subpopulation AFR AF = 0.00897 (373/41560). AF 95% confidence interval is 0.00822. There are 2 homozygotes in GnomAd4. There are 224 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015896.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZMYND10
NM_015896.4
MANE Select
c.727C>Tp.Arg243Cys
missense
Exon 8 of 12NP_056980.2
ZMYND10
NM_001308379.2
c.712C>Tp.Arg238Cys
missense
Exon 7 of 11NP_001295308.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZMYND10
ENST00000231749.8
TSL:1 MANE Select
c.727C>Tp.Arg243Cys
missense
Exon 8 of 12ENSP00000231749.3
ZMYND10
ENST00000360165.7
TSL:1
c.712C>Tp.Arg238Cys
missense
Exon 7 of 11ENSP00000353289.3
ZMYND10
ENST00000442887.1
TSL:1
c.598C>Tp.Arg200Cys
missense
Exon 8 of 9ENSP00000393687.1

Frequencies

GnomAD3 genomes
AF:
0.00316
AC:
481
AN:
152178
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00900
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.00957
GnomAD2 exomes
AF:
0.00113
AC:
284
AN:
250592
AF XY:
0.00101
show subpopulations
Gnomad AFR exome
AF:
0.00986
Gnomad AMR exome
AF:
0.00145
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000539
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000662
AC:
968
AN:
1461296
Hom.:
1
Cov.:
32
AF XY:
0.000655
AC XY:
476
AN XY:
726818
show subpopulations
African (AFR)
AF:
0.00843
AC:
282
AN:
33470
American (AMR)
AF:
0.00163
AC:
73
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26112
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5760
European-Non Finnish (NFE)
AF:
0.000462
AC:
513
AN:
1111566
Other (OTH)
AF:
0.00146
AC:
88
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00316
AC:
481
AN:
152296
Hom.:
2
Cov.:
33
AF XY:
0.00301
AC XY:
224
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00897
AC:
373
AN:
41560
American (AMR)
AF:
0.00307
AC:
47
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
68020
Other (OTH)
AF:
0.00947
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00117
Hom.:
1
Bravo
AF:
0.00377
ESP6500AA
AF:
0.0104
AC:
46
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00133
AC:
161
EpiCase
AF:
0.000927
EpiControl
AF:
0.000830

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ZMYND10: BP4

Primary ciliary dyskinesia 22 Benign:1
Apr 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.37
T
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.71
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.34
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-3.8
D
REVEL
Benign
0.11
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.011
D
Polyphen
0.99
D
Vest4
0.26
MVP
0.030
MPC
0.22
ClinPred
0.036
T
GERP RS
2.9
Varity_R
0.18
gMVP
0.27
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141055331; hg19: chr3-50379974; API